神经系统遗传性疾病分子遗传学和分子诊断历史回顾与展望
Review and perspective of molecular genetics and molecular diagnosis in neurogenetic disorders
摘要
神经系统遗传性疾病(neurogenetic disorders)系指由遗传物质(染色体、基因或线粒体)的数量、结构和功能改变所致的以神经系统功能异常为主要临床表现的疾病。依据引起遗传物质改变的起源组织不同,可将神经系统遗传性疾病分为两种类型:I型系由神经元外胚层来源的基因表达异常,
出处
《中国现代神经疾病杂志》
CAS
2012年第3期231-232,共2页
Chinese Journal of Contemporary Neurology and Neurosurgery
参考文献7
-
1Hoffman EP, Brown RH Jr, Kunkel LM. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell, 1987, 51:919-928.
-
2Gusella JF, Wexler NS, Conneally PM, et al. A polymorphic DNA marker genetically linked to Huntington's disease. Nature, 1983, 306:234-238.
-
3Tagle DA, Blanchard - McQuate KL, Valdes J, et al. Dinucleotide repeat polymorphism in the Huntington's disease region at the D4S182 locus. Hum Mol Genet, 1993, 2:489.
-
4王柠,林宇,陈万金.神经遗传性疾病的基因学研究十年进展[J].中国现代神经疾病杂志,2010,10(1):71-73. 被引量:2
-
5Wang JL, Yang X, Xia K, et al. TGM6 identified as a novel causative gene of spinocerebellar ataxias using exome sequencing. Brain, 2010, 133(Pt 12):3510-3518.
-
6Wang JL, Cao L, Li XH, et al. Identification of PRRT2 as the causative gene of paroxysmal kinesigenic dyskinesias. Brain, 2011, 134(Pt 12):3493-3501.
-
7Botstein D, White RL, Skolnick M, et al. Construction of a genetic linkage map in man using restriction fragment length polymorphisms. Am J Hum Genet, 1980, 32:314-331.
二级参考文献18
-
1张如旭,唐北沙,资晓宏,罗巍,夏昆,潘乾,龙志高,胡正茂,李小波.腓骨肌萎缩症GDAP1基因突变分析[J].中华医学遗传学杂志,2004,21(3):207-210. 被引量:21
-
2Hagerman RJ, Leehey M, Heinrichs W, et al. Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology, 2001, 57:127-130.
-
3Gregorevic P, Blankinship M J, Allen JM, et al. Systemic delivery of genes to striated muscles using adeno- associated viral vectors. Nat Med, 2004, 10:828-834.
-
4Welch EM, Barton ER, Zhuo J, et al. PTC124 targets genetic disorders caused by nonsense mutations. Nature, 2007, 447:87- 91.
-
5van Deutekom JC, Janson AA, Ginjaar IB, et al. Local dystrophin restoration with antisense oligonucleotide PRO051. N Engl J Med, 2007, 357:2677-2686.
-
6Kinali M, Arechavala- Gomeza V, Feng L, et al. Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single- blind, placebo - controlled, dose - escalation, proof- of- concept study. Lancet Neurol, 2009, 8:918-928.
-
7Cartier N, Hacein- Bey- Abina S, Bartholomae CC, et al. Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science, 2009, 326:818-823.
-
8Gregory SG, Barlow KF, McLay KE, et al. The DNA sequence and biological annotation of human chromosome 1. Nature, 2006, 441:315-321.
-
9Margulies M, Egholm M, Altman WE, et al. Genome sequencing in microfabricated high- density picolitre reactors. Nature, 2005, 437:376-380.
-
10Bentley DR. Whole-genome re-sequencing. Curr Opin Genet Dev, 2006, 16:545-552.
-
1王柠,陈万金,林宇.我国神经系统遗传性疾病的研究现状及展望[J].中国现代神经疾病杂志,2008,8(2):95-98. 被引量:2
-
2李念虎,李刚.神经纤维瘤病性颈椎后凸1例报告[J].中国脊柱脊髓杂志,2005,15(4):198-198.
-
3曾志锋.疾病的真相[J].医药保健杂志,2007(09X):52-53.
-
4黄家喜,周辛味.结节性硬化症合并神经纤维瘤1例分析[J].中国优生与遗传杂志,1994,2(2):108-108.
-
5徐慧文.一家系中3例肝豆状核变性报告[J].北京医学,2009,31(8):508-509.
-
6梁秀龄.解读《肝豆状核变性的诊断与治疗指南》[J].中国现代神经疾病杂志,2009,9(3):212-215. 被引量:36
-
7陈生弟,王刚.分子生物学技术在神经系统遗传性疾病诊断中的应用[J].诊断学理论与实践,2004,3(2):72-73. 被引量:1
-
8Wexler NS,陈嵘.Huntington病可作为神经系统遗传性疾病分子研究途径的范例[J].国外医学(遗传学分册),1992,15(6):312-316.
-
9顾统元,刘冰怀.急性心肌梗塞血浆5—羟色胺和有关物质改变及临床意义[J].中华心血管病杂志,1989,17(3):153-154. 被引量:4
-
10张莹,冯伟,燕存子,西艾木西卡买尔.艾合买提,林勇,刘晖.肺栓塞大鼠血管活性物质改变及抗凝药物对其影响[J].中国应用生理学杂志,2015,31(2):178-181. 被引量:10